The 8 most recent market catalysts affecting $ENOV, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 55
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $33
Wells Fargo analyst Larry Biegelsen maintained an 'Overweight' rating on Enovis, signaling a belief that the stock will outperform the broader market. However, the price target was…
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 55
Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Citizens analyst David Turkaly has adjusted Enovis's price target downwards from $55 to $47. This change, while maintaining a 'Market Outperform' rating, signals a recalibration of…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 75
Enovis shares are trading lower. The company announced a binding offer to acquire eCential Robotics for an upfront enterprise value of €155 million.
The acquisition of eCential Robotics by Enovis is a significant corporate catalyst for ENOV. While strategically sound for long-term growth in the orthopedic robotics sector, the i…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 92
Enovis Enters Into Binding Offer To Acquire eCential Robotics For Upfront Enterprise Value Of €155 Mln
Enovis announced a binding offer to acquire eCential Robotics for an upfront enterprise value of €155 million, with potential additional contingent consideration. This acquisition …
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $39
Wells Fargo analyst Larry Biegelsen maintained an 'Overweight' rating on Enovis, signaling a continued belief in the company's long-term potential. However, the slight reduction in…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Enovis, Raises Price Target to $40
BTIG analyst Ryan Zimmerman reiterated a 'Buy' rating on Enovis (ENOV) and raised the price target from $39 to $40. This action signals continued analyst confidence in Enovis's bus…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Enovis Q2 Adj. EPS $0.90 Beats $0.85 Estimate, Sales $582.782M Beat $582.542M Estimate
Enovis announced its Q2 earnings, reporting an adjusted EPS of $0.90, which surpassed the analyst consensus of $0.85 by 5.88%. Additionally, quarterly sales reached $582.782 millio…
Aug 6, 2026
Corporate Catalyst
Neutral
Impact 55
Enovis Affirms FY2026 Adj EPS Guidance of $3.52-$3.73 vs $3.65 Est; Affirms FY2026 Sales Guidance of $2.310B-$2.370B vs $2.345B Est
Enovis filed an 8-K to affirm its financial guidance for fiscal year 2026, specifically for adjusted EPS and sales. This means the company is not revising its previous projections,…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.